PRAX

302.6702.65%
JA

Jeffrey Allan Chodakewitz

Independent Director

Dr. Jeffrey Allan Chodakewitz, also known as Jeff, is Scientific Advisor of TriGemX Bio, Inc. Dr. Chodakewitz serves as Partner at Ascenta Capital Management Co., L.P. since 2026, where he also served as Advisory Partner until 2026. He serves as Independent Director of Schrödinger, Inc. since April 2020, Independent Director of Adicet Bio, Inc. since September 15, 2020, Independent Director of Praxis Precision Medicines, Inc. since April 2021 and Independent Non-Executive Director of Freeline Therapeutics Limited since August 2019. Dr. Chodakewitz also serves as Scientific Advisors of Kallyope, Inc. and volunteers as an Entrepeneur-in-Residence with Yale Ventures. His prior roles include serving as an Executive/Senior Advisor at Blackstone Life Sciences until 2022. He served as Independent Non-Executive Director of Spur Therapeutics Limited from August 2019 to February 2024 and as Independent Director of Tetraphase Pharmaceuticals, Inc. from June 17, 2014 to July 28, 2020. From 2014 to 2019, he was at Vertex Pharmaceuticals Incorporated, serving as Chief Medical Officer and Executive VP of Global Medicines Development & Medical Affairs until March 31, 2018 and subsequently as Senior Advisor. He also served as Independent Director of resTORbio, Inc. from August 14, 2018 and as a Member of the Clinical Development Advisory Board of Kallyope, Inc. from August 2022. Previously, Dr. Chodakewitz held several senior roles at Merck & Co., including SVP of Late Development, VP of Early Development and VP of Infectious Diseases & Vaccines. Dr. Chodakewitz has several years of experience in the pharmaceutical and biotech industry with broad experience across both Early and Late Development. His clinical training was in internal medicine and infectious diseases. At Merck, his work involved novel potential medicines, including leading the effort to develop an HIV protease inhibitor. At Vertex, he oversaw the development and global approval of multiple innovative medicines. Dr. Chodakewitz received his B.S. in Biochemistry from Yale University and M.D. from Yale University School of Medicine. He trained in Internal Medicine at NYU/Bellevue and completed his fellowship in Infectious Diseases at Yale.

Positions